AlphaMol Science AG develops and applies integrated approaches combining computational biology, biochemistry, medicinal chemistry, pharmacology and biotechnology to support small-molecule drug discovery and design. The company’s activities include GPCR molecular research, in vitro biotesting, membrane protein structure studies and development of computational algorithms for drug discovery.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Active ingredient research and active ingredient design
Active ingredient research and active ingredient design using computational biology, biochemistry, medicinal chemistry, pharmacology and biotechnology for the development of modern new medicines.
GPCR research and GPCR biotesting
GPCR molecular research, innovative GPCR biotesting and analyses focused on GPCR target structures for drug development.
Membrane protein structure determination
Resolving membrane protein structures in native lipids for structural studies and support for target and active ingredient research.
Computational algorithm development for pharmaceutical research
New computational algorithm development to support data analysis, modelling and more efficient drug discovery.
Knowledge
No knowledge articles yet
Once AlphaMol Science AG has claimed this profile, we'll publish editorial articles and case studies here together.